Nutanix, Inc. (NTNX) Reaches $34.24 After 9.00% Up Move; Smith & Nephew plc (LON:SN) Covered By 7 Bulls

February 14, 2018 - By Adrian Erickson

The stock of Nutanix, Inc. (NASDAQ:NTNX) is a huge mover today! The stock increased 3.16% or $1.05 during the last trading session, reaching $34.24. About 1.18 million shares traded. Nutanix, Inc. (NASDAQ:NTNX) has 0.00% since February 14, 2017 and is . It has underperformed by 16.70% the S&P500.The move comes after 6 months positive chart setup for the $5.49 billion company. It was reported on Feb, 14 by Barchart.com. We have $37.32 PT which if reached, will make NASDAQ:NTNX worth $494.37M more.

Among 20 analysts covering Smith Nephew PLC (LON:SN), 7 have Buy rating, 1 Sell and 12 Hold. Therefore 35% are positive. Smith Nephew PLC had 209 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by UBS with “Buy” on Friday, July 31. As per Tuesday, March 1, the company rating was maintained by Numis Securities. The firm has “Hold” rating by Beaufort Securities given on Tuesday, August 9. The stock of Smith & Nephew plc (LON:SN) has “Outperform” rating given on Monday, December 7 by Bernstein. JP Morgan maintained Smith & Nephew plc (LON:SN) on Tuesday, October 10 with “Neutral” rating. The stock of Smith & Nephew plc (LON:SN) has “Outperform” rating given on Tuesday, February 9 by Bernstein. The stock of Smith & Nephew plc (LON:SN) earned “Hold” rating by Deutsche Bank on Monday, August 1. The rating was maintained by Jefferies on Wednesday, March 29 with “Buy”. The firm has “Neutral” rating given on Friday, April 8 by JP Morgan. Jefferies maintained it with “Buy” rating and GBX 1515 target in Friday, July 28 report. See Smith & Nephew plc (LON:SN) latest ratings:




13/02/2018 Broker: Morgan Stanley Rating: Equal Weight Old Target: GBX 1558.00 New Target: GBX 1457.00 Maintain
09/02/2018 Broker: Credit Suisse Rating: Neutral Old Target: GBX 1285.00 New Target: GBX 1290.00 Reiteration
07/02/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 1411.00 New Target: GBX 1411.00 Maintain
01/02/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 1411.00 New Target: GBX 1411.00 Maintain
25/01/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 1369.00 New Target: GBX 1411.00 Upgrade
13/11/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 1382.00 New Target: GBX 1369.00 Maintain
06/11/2017 Broker: Jefferies Rating: Buy Old Target: GBX 1515.00 New Target: GBX 1515.00 Maintain
06/11/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 1382.00 New Target: GBX 1382.00 Maintain
03/11/2017 Broker: Berenberg Rating: Hold Old Target: GBX 1340.00 New Target: GBX 1340.00 Maintain
23/10/2017 Broker: Deutsche Bank Rating: Hold Old Target: GBX 1200.00 New Target: GBX 1315.00 Maintain

Investors sentiment increased to 1.14 in Q3 2017. Its up 0.01, from 1.13 in 2017Q2. It increased, as 31 investors sold Smith & Nephew plc shares while 27 reduced holdings. 25 funds opened positions while 41 raised stakes. 48.05 million shares or 15.77% less from 57.05 million shares in 2017Q2 were reported. California Employees Retirement Systems holds 294,800 shares or 0% of its portfolio. Parametric Assoc Llc has invested 0% in Smith & Nephew plc (LON:SN). 1,500 are held by Pnc Fincl Group Inc. Jefferies Group Ltd Liability Com holds 0% or 156,400 shares in its portfolio. Cubist Systematic Strategies Ltd Liability Corporation has invested 0.01% of its portfolio in Smith & Nephew plc (LON:SN). Columbia Pacific Lc, Washington-based fund reported 286,432 shares. Parallax Volatility Advisers Ltd Partnership owns 207,280 shares. Paloma Prtn Management reported 126,131 shares or 0.01% of all its holdings. Royal Comml Bank Of Canada owns 0% invested in Smith & Nephew plc (LON:SN) for 11,786 shares. Oppenheimer Asset Management has invested 0% in Smith & Nephew plc (LON:SN). Round Table Service Ltd Company invested in 139,300 shares or 0.24% of the stock. Oppenheimer And Com holds 0.01% or 104,310 shares in its portfolio. Stratos Wealth Ptnrs Limited has 0.01% invested in Smith & Nephew plc (LON:SN). Assetmark has invested 0% in Smith & Nephew plc (LON:SN). Cypress Capital Mngmt Ltd Liability Corp (Wy) owns 1,500 shares.

The stock increased 1.24% or GBX 15.5 during the last trading session, reaching GBX 1264. About 2.92 million shares traded. Smith & Nephew plc (LON:SN) has 0.00% since February 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Since October 10, 2017, it had 0 insider buys, and 5 insider sales for $618,178 activity. Thill Howard J SR also sold $70,368 worth of Smith & Nephew plc (LON:SN) shares. Hink Kirsten A also sold $51,934 worth of Smith & Nephew plc (LON:SN) on Monday, January 8. Heinson Christopher had sold 19,903 shares worth $103,894 on Monday, January 8. Kopel Gregory B had sold 7,960 shares worth $44,664. The insider SANCHEZ ANTONIO R JR sold $347,318.

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company has market cap of 11.06 billion GBP. The firm offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints; and arthroscopic enabling technologies for healthcare providers, such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. It has a 14.41 P/E ratio. It also provides trauma and extremities products consisting of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery services and products; knee implant products for specialized knee replacement procedures; and hip implant products for reconstruction of the hip joint, as well as various products and technologies to assist in surgical treatment of the ear, nose, and throat.

Among 13 analysts covering Nutanix (NASDAQ:NTNX), 7 have Buy rating, 0 Sell and 6 Hold. Therefore 54% are positive. Nutanix had 13 analyst reports since October 25, 2016 according to SRatingsIntel. The firm has “Outperform” rating given on Tuesday, October 25 by RBC Capital Markets. The firm has “Hold” rating given on Tuesday, October 25 by Stifel Nicolaus. The firm has “Overweight” rating by Pacific Crest given on Tuesday, October 25. Robert W. Baird initiated Nutanix, Inc. (NASDAQ:NTNX) rating on Tuesday, October 25. Robert W. Baird has “Outperform” rating and $37 target. The rating was initiated by Piper Jaffray on Tuesday, October 25 with “Overweight”. The stock of Nutanix, Inc. (NASDAQ:NTNX) has “Mkt Perform” rating given on Tuesday, October 25 by Raymond James. The firm has “Equal-Weight” rating by Morgan Stanley given on Tuesday, October 25. The stock of Nutanix, Inc. (NASDAQ:NTNX) has “Outperform” rating given on Tuesday, October 25 by Oppenheimer. Needham initiated it with “Buy” rating and $36 target in Tuesday, October 25 report. Credit Suisse initiated the shares of NTNX in report on Tuesday, October 25 with “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.